Shandong Teamgene Technology Co. Ltd. A
Shandong Teamgene Technology Co., Ltd. engages in the research, development, production, and sale of pig feed that focuses on animal life and animal nutrition research in China. It offers pig feed, egg and poultry premixes, meat ruminant feed, and aquatic products, as well as sales veterinary drug. The company was founded in 2007 and is based in Zibo, China.
Shandong Teamgene Technology Co. Ltd. A (603151) - Total Liabilities
Latest total liabilities as of June 2025: CN¥1.48 Billion CNY
Based on the latest financial reports, Shandong Teamgene Technology Co. Ltd. A (603151) has total liabilities worth CN¥1.48 Billion CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shandong Teamgene Technology Co. Ltd. A - Total Liabilities Trend (2020–2024)
This chart illustrates how Shandong Teamgene Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shandong Teamgene Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shandong Teamgene Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Smart Parking Ltd
AU:SPZ
|
Australia | AU$42.15 Million |
|
SpareBank 1 Nord-Norge
PINK:SPXXF
|
USA | $12.51 Billion |
|
Zhejiang Yaguang Technology Co. Ltd. A
SHG:603282
|
China | CN¥1.25 Billion |
|
Responsive Industries Limited
NSE:RESPONIND
|
India | ₹3.88 Billion |
|
Selvita S.A.
WAR:SLV
|
Poland | zł294.51 Million |
|
Vef AB
ST:VEFAB
|
Sweden | Skr29.87 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Shandong Teamgene Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Teamgene Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Teamgene Technology Co. Ltd. A (2020–2024)
The table below shows the annual total liabilities of Shandong Teamgene Technology Co. Ltd. A from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥518.56 Million | +121.82% |
| 2023-12-31 | CN¥233.77 Million | +43.20% |
| 2022-12-31 | CN¥163.25 Million | +33.45% |
| 2021-12-31 | CN¥122.33 Million | -24.43% |
| 2020-12-31 | CN¥161.87 Million | -- |